• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.73% Nasdaq Down 0.96%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    3.99 Down 0.06(1.48%) Jul 27, 4:00PM EDT
    |After Hours : 4.21 Up 0.22 (5.51%) Jul 27, 6:46PM EDT
    Add to Portfolio
    Prev Close:4.05
    Open:4.02
    Bid:3.98 x 2000
    Ask:4.21 x 31000
    1y Target Est:7.70
    Beta:-0.62
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:3.91 - 4.07
    52wk Range:3.26 - 6.28
    Volume:1,967,312
    Avg Vol (3m):2,747,760
    Market Cap:965.74M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 1.48%965.74M
    GSKUp 0.51%100.46B
    OREXUp 0.48%527.18M
    RHHBYDown 1.00%242.44B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback